Neuberg, Star Imaging in joint venture to expand integrated diagnostics across Maharashtra
Live Events
(You can now subscribe to our
(You can now subscribe to our Economic Times WhatsApp channel
Neuberg Diagnostics, a leading diagnostic service provider, formed a joint venture with Maharashtra-based Star Imaging , a leader in advanced medical imaging , to expand integrated diagnostic centres across the state, a top official said on Wednesday. In a press release, the Chennai-headquartered Neuberg Diagnostics noted that radiology and pathology have traditionally operated in silos. By bringing together multiple diagnostic modalities-radiology, pathology, wellness, and genomics-under one roof, integrated diagnostics improves accuracy and speeds up diagnosis.The partnership between Neuberg Diagnostics and Star Imaging addresses this gap by offering a unified, patient-centric approach to diagnostics, the release added."At Neuberg Diagnostics, our mission has always been to make world-class diagnostic services accessible and affordable, regardless of geography. This joint venture with Star Imaging is a strategic step toward achieving that goal in Maharashtra," said GSK Velu, Chairman and Managing Director of Neuberg Diagnostics."By combining our strengths in pathology, radiology, wellness, and genomics, we are building one of the most comprehensive and technologically advanced diagnostic networks in the state. This partnership allows us to offer deeper diagnostic insights to clinicians and deliver better outcomes for patients," he added.Speaking on the expansion in Maharashtra, Velu said, "This collaboration lays a strong foundation for long-term investment, infrastructure development, and the democratisation of high-quality healthcare diagnostics."As part of the expansion plan, Neuberg aims to launch new integrated diagnostic centres in Pune, Nashik, Nagpur, Aurangabad, and other key cities in Maharashtra over the next two years."Our goal is to provide patients and clinicians with fast, accurate, and integrated diagnostic insights that enable early detection, precise treatment decisions, and improved health outcomes," said Star Imaging Director Ashish Atre."We are excited about the opportunity to scale this model across Maharashtra and bring advanced diagnostics closer to those who need it most," he added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
35 minutes ago
- Time of India
Forget ozempic, this natural fibre mimics its effects, aiding dramatic weight loss and blood sugar control, say experts
Fibre's comeback moment What's so special about beta-glucan? Live Events More than just weight loss Foods that are rich in beta-glucan Oats Barley Sorghum Rye Maize (corn) Triticale (a wheat-rye hybrid) Wheat and durum wheat Rice Mushrooms Seaweed (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel We've all heard about Ozempic , the diabetes drug that's become popular for its strong weight loss effects. But what if a simple, natural ingredient like fibre could do something similar?That's what a new study from the University of Arizona and the University of Vienna suggests. Researchers have found that beta-glucan , a special type of fibre found in oats and barley, may help with weight loss and blood sugar control , just like Ozempic, but without any a long time, fibre wasn't the star of the nutrition world. People mostly focused on carbs and protein. But now, fibre is making a comeback, especially as we learn more about how it helps our gut and overall gut is home to trillions of tiny bacteria, known as the gut microbiome . These bacteria love fibre. In return, they help us digest food, fight off illness, and even manage weight. In the new 2024 study, scientists gave different types of fibre to mice who were on a high-fat diet . Only one type worked for weight loss: is a soluble fibre. That means it dissolves in water and can be easily used by gut bacteria. You can find it in common whole grains like oats and the study, mice that ate beta-glucan didn't eat less food, but they still lost weight and fat. Their metabolism changed. One of the biggest changes was an increase in a helpful gut bacterium called Ileibacterium, which other studies have also linked to weight key change was the production of a chemical called butyrate. This is made when gut bacteria digest fibre. Butyrate helps your body release GLP-1, a hormone that reduces hunger. Ozempic works by mimicking this same hormone. So in simple terms, beta-glucan might help your body make more of this hormone doesn't just help with weight. It also protects the lining of your gut, supports the liver, and may lower inflammation. Scientists say we still have a lot to learn, but the early signs are said, remember: this research was done in mice. We still need more studies in humans to be sure it works the same beta-glucan to your diet is easy. Here are some foods that naturally contain it:These foods slow down digestion, which keeps you full for longer and helps your body manage blood sugar from TOI
&w=3840&q=100)
Business Standard
41 minutes ago
- Business Standard
Puravankara shares nosedive 10% as Q4 loss widens; results breakdown here
Shares of Puravankara plunged nearly 10 per cent in Monday's intraday trade after its loss in the fourth quarter of the financial year 2024-25 widened to ₹88 crore along with a decline in the top line. The real estate major's stock fell as much as 9.98 per cent during the day to ₹258.9 per share, the biggest intraday loss since April 7 this year. As of 11:15 AM, the stock was down 9.3 per cent at ₹239 apiece, compared to a 0.52 per cent decline in Nifty50. Shares of the company currently trade at the lowest level since May 14 this year, and have fallen 36 per cent this year, compared to a 4.1 per cent advance in the benchmark Nifty50. Puravankara has a total market capitalisation of ₹5,695.15 crore, according to BSE data. Puravankara Q4 results The Bengaluru-headquartered company saw its fourth quarter loss widen to ₹88 crore, from a loss of ₹6.71 crore in the same quarter last financial year. Revenue from operations for the quarter declined 40.4 per cent to ₹563.7 crore from ₹946.8 crore in the corresponding period of the previous year. The company's inventory rose to ₹430 crore in Q4FY25, up from ₹45.48 crore in the same quarter last year. The land purchase cost more than doubled to ₹191.8 crore from ₹87.6 crore during the period. Sub-contractor costs also rose to ₹424 crore versus ₹397 crore, contributing to the overall income turning negative. In Q4FY25, pre-sales stood at ₹1,282 crore, driven by a sales volume of 1.42 million square feet and collections of ₹946 crore. For the full year FY25, the company achieved pre-sales of ₹5,006 crore, with a sales volume of 5.67 million square feet and a 10 per cent year-on-year (Y-o-Y) increase in sales realisation. 'FY25 saw record sustenance sales, and our western India investments are now poised to come to market. We are also actively pursuing several major redevelopment projects," said Ashish Puravankara, Managing Director of Puravankara. "With over 13.5 million square feet in the pipeline group-wide, and key approvals in place, we are optimistic about delivering long-term value to all stakeholders while reinforcing our legacy of trust and innovation.' Puravankara FY26 outlook
News18
an hour ago
- News18
3B Films IPO Day 2: Check Subscription Status, GMP Today
Last Updated: 3B Films Ltd's IPO was subscribed 1.20 times by Day 2, with retail at 1.66 times. The IPO price is Rs 50, and shares trade at Rs 53 in the grey market. It closes on June 3. 3B Films IPO Day 2: The initial public offering of 3B Films Ltd, which was opened for public subscription on Friday, May 30, has received a muted response till Day 2 so far. Till 1:29 pm on the second day of bidding on Monday, the Rs 33.75-crore BSE IPO received a 1.20 times subscription, garnering bids for 76,71,000 shares as against 64,08,001 shares on offer. The retail and NII participation stood at 1.66 times and 0.73 times, respectively. Gujarat-based 3B Films manufactures and supplies cast polypropylene (CPP) and cast polyethylene (CPE) films. The three-day IPO will be closed on Tuesday, June 3. It received a 0.86 times subscription on the first day of bidding on Friday. 3B Films IPO Price The price has been fixed in the range of Rs 50 apiece. 3B Films IPO GMP Today According to market observers, unlisted shares of 3B Films Ltd are currently trading at Rs 53 apiece in the grey market, which is a 6% premium or GMP over the IPO price of Rs 50. It indicates listing gains for investors on June 6, the tentative listing date. The shares will be listed on the BSE's SME platform. The GMP is based on market sentiments and keeps changing. 'Grey market premium' indicates investors' readiness to pay more than the issue price. The minimum lot size for an application is 3,000. The minimum amount of investment required by retail investors is Rs 1,50,000. The bidding can be done in multiple of 3,000. 3B Films IPO: More Details The company is planning to raise Rs 33.75 crore through a fresh issue of 3.54 million equity shares and an offer-for-sale (OFS) of 3.19 million shares. The SME IPO will close for subscription on Tuesday, June 3, 2025. The basis of the allotment of shares is expected to be finalised on Wednesday, June 4, 2025. Maashitla Securities is the registrar of the issue. Nirbhay Capital Services is the sole book-running lead manager for the issue. According to the red herring prospectus (RHP), from the net fresh issue proceeds, the company aims to use Rs 4.43 crore for capital expenditure, Rs 7.15 crore for working capital requirements and Rs 4.43 crore for general corporate purposes.
